Literature DB >> 14601580

Protease and reverse transcriptase mutation patterns in HIV type 1 isolates from heavily treated persons: comparison of isolates from Northern California with isolates from other regions.

Matthew J Gonzales1, Ilana Belitskaya, Kathryn M Dupnik, Soo-Yon Rhee, Robert W Shafer.   

Abstract

We compared HIV-1 subtype B reverse transcriptase (RT) and protease mutation patterns in isolates from heavily treated persons in Northern California with those from persons described in the published literature predominantly from other parts of the United States and Europe. There were few differences in the prevalence of single, double, and triple mutations between the two sets of sequences. More complex patterns of mutations could be characterized by clustering the sequences into eight groups of RT sequences and nine groups of protease sequences according to the presence of known drug-resistance mutations. This clustering accounted for 63% of the variation at RT inhibitor-resistance positions and 68% of the variation at protease inhibitor-resistance positions. The majority of clusters contained Northern California and literature sequences in similar proportions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601580      PMCID: PMC2547469          DOI: 10.1089/088922203322493085

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

Authors:  K Hertogs; S Bloor; S D Kemp; C Van den Eynde; T M Alcorn; R Pauwels; M Van Houtte; S Staszewski; V Miller; B A Larder
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

2.  Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population.

Authors:  M J Gonzales; R N Machekano; R W Shafer
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

3.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

4.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors:  J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

5.  Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database.

Authors:  R W Shafer; D Stevenson; B Chan
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

6.  Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients.

Authors:  R W Shafer; M A Winters; S Palmer; T C Merigan
Journal:  Ann Intern Med       Date:  1998-06-01       Impact factor: 25.391

  6 in total
  4 in total

1.  Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations.

Authors:  Elizabeth Johnston; Kathryn M Dupnik; Matthew J Gonzales; Mark A Winters; Soo-Yon Rhee; Tomozumi Imamichi; Robert W Shafer
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

2.  HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

Authors:  Soo-Yon Rhee; W Jeffrey Fessel; Andrew R Zolopa; Leo Hurley; Tommy Liu; Jonathan Taylor; Dong Phuong Nguyen; Sally Slome; Daniel Klein; Michael Horberg; Jason Flamm; Stephen Follansbee; Jonathan M Schapiro; Robert W Shafer
Journal:  J Infect Dis       Date:  2005-07-05       Impact factor: 5.226

3.  Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing.

Authors:  Soo-Yon Rhee; Tommy Liu; Jaideep Ravela; Matthew J Gonzales; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.

Authors:  Kathleen M Doherty; Priyanka Nakka; Bracken M King; Soo-Yon Rhee; Susan P Holmes; Robert W Shafer; Mala L Radhakrishnan
Journal:  BMC Bioinformatics       Date:  2011-12-15       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.